{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:57:37Z","timestamp":1790351857970,"version":"4.1.0"},"reference-count":138,"publisher":"Elsevier","isbn-type":[{"value":"9780128201763","type":"print"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/bs.acr.2020.01.003","type":"book-chapter","created":{"date-parts":[[2020,2,29]],"date-time":"2020-02-29T16:32:46Z","timestamp":1582993966000},"page":"23-56","source":"Crossref","is-referenced-by-count":30,"title":["Age-related disparities in older women with breast cancer"],"prefix":"10.1016","member":"78","reference":[{"issue":"19","key":"10.1016\/bs.acr.2020.01.003_bb0010","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1002\/cncr.30842","article-title":"Comparison of recommendations for screening mammography using CISNET models","volume":"123","author":"Arleo","year":"2017","journal-title":"Cancer"},{"issue":"11A","key":"10.1016\/bs.acr.2020.01.003_bb0015","first-page":"221","article-title":"General guidelines for the management of older patients with cancer","volume":"14","author":"Balducci","year":"2000","journal-title":"Oncology"},{"issue":"1","key":"10.1016\/bs.acr.2020.01.003_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-014-2994-7","article-title":"Breast cancer and aging: Results of the U13 conference breast cancer panel","volume":"146","author":"Barginear","year":"2014","journal-title":"Breast Cancer Research and Treatment"},{"issue":"17","key":"10.1016\/bs.acr.2020.01.003_bb0025","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1056\/NEJMoa050518","article-title":"Effect of screening and adjuvant therapy on mortality from breast cancer","volume":"353","author":"Berry","year":"2005","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.acr.2020.01.003_bb0030","first-page":"115","article-title":"Treatment of breast Cancer in women aged 80 and older: A systematic review","volume":"1","author":"Blair","year":"2016","journal-title":"Breast Cancer: Current Research"},{"issue":"21","key":"10.1016\/bs.acr.2020.01.003_bb0035","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1206809","article-title":"Effect of three decades of screening mammography on breast-cancer incidence","volume":"367","author":"Bleyer","year":"2012","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1016\/bs.acr.2020.01.003_bb0040","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3816\/CBC.2010.n.042","article-title":"Axillary lymph node involvement in women with breast cancer: Does it depend on age?","volume":"10","author":"Botteri","year":"2010","journal-title":"Clinical Breast Cancer"},{"issue":"19","key":"10.1016\/bs.acr.2020.01.003_bb0045","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1200\/JCO.2003.02.046","article-title":"Undertreatment strongly decreases prognosis of breast cancer in elderly women","volume":"21","author":"Bouchardy","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/bs.acr.2020.01.003_bb0050","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/CIA.S65304","article-title":"Optimal breast cancer screening strategies for older women: Current perspectives","volume":"11","author":"Braithwaite","year":"2016","journal-title":"Clinical Interventions in Aging"},{"issue":"2","key":"10.1016\/bs.acr.2020.01.003_bb0055","doi-asserted-by":"crossref","first-page":"253e","DOI":"10.1097\/PRS.0000000000000988","article-title":"Advanced age is a predictor of 30-day complications after autologous but not implant-based postmastectomy breast reconstruction","volume":"135","author":"Butz","year":"2015","journal-title":"Plastic and Reconstructive Surgery"},{"issue":"33","key":"10.1016\/bs.acr.2020.01.003_bb0060","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1200\/JCO.2013.48.7884","article-title":"Trastuzumab-related cardiotoxicity among older patients with breast cancer","volume":"31","author":"Chavez-MacGregor","year":"2013","journal-title":"Journal of Clinical Oncology"},{"issue":"10","key":"10.1016\/bs.acr.2020.01.003_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165409","article-title":"Effect of age on breast Cancer patient prognoses: A population-based study using the SEER 18 database","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/bs.acr.2020.01.003_bb0070","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1200\/JCO.2015.63.8619","article-title":"Treatment adherence and its impact on disease-free survival in the breast international group 1-98 trial of tamoxifen and Letrozole, alone and in sequence","volume":"34","author":"Chirgwin","year":"2016","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1016\/bs.acr.2020.01.003_bb0075","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10549-015-3647-1","article-title":"Benefit\/risk for adjuvant breast cancer therapy with tamoxifen or aromatase inhibitor use by age, and race\/ethnicity","volume":"154","author":"Chlebowski","year":"2015","journal-title":"Breast Cancer Research and Treatment"},{"issue":"4","key":"10.1016\/bs.acr.2020.01.003_bb0080","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jamcollsurg.2012.06.017","article-title":"Optimal preoperative assessment of the geriatric surgical patient: A best practices guideline from the American College of Surgeons National Surgical Quality Improvement Program and the American Geriatrics Society","volume":"215","author":"Chow","year":"2012","journal-title":"Journal of the American College of Surgeons"},{"issue":"8","key":"10.1016\/bs.acr.2020.01.003_bb0085","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/jnci\/djs145","article-title":"Biological, clinical, and psychosocial correlates at the interface of cancer and aging research","volume":"104","author":"Dale","year":"2012","journal-title":"Journal of the National Cancer Institute"},{"issue":"6","key":"10.1016\/bs.acr.2020.01.003_bb0090","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.clbc.2016.06.017","article-title":"Adjuvant radiation improves survival in older women following breast-conserving surgery for estrogen receptor-negative breast Cancer","volume":"16","author":"Daugherty","year":"2016","journal-title":"Clinical Breast Cancer"},{"issue":"9472","key":"10.1016\/bs.acr.2020.01.003_bb0095","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials","volume":"365","year":"2005","journal-title":"Lancet"},{"issue":"9804","key":"10.1016\/bs.acr.2020.01.003_bb0100","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data for 10,801 women in 17 randomised trials","volume":"378","author":"Darby","year":"2011","journal-title":"Lancet"},{"issue":"9814","key":"10.1016\/bs.acr.2020.01.003_bb0105","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(11)61625-5","article-title":"Comparisons between different polychemotherapy regimens for early breast cancer: Meta-analyses of long-term outcome among 100,000 women in 123 randomized trials","volume":"379","author":"Peto","year":"2012","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/bs.acr.2020.01.003_bb0110","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1002\/cncr.30142","article-title":"Benefit of adjuvant radiotherapy after breast-conserving therapy among elderly women with T1-T2N0 estrogen receptor-negative breast cancer","volume":"122","author":"Eaton","year":"2016","journal-title":"Cancer"},{"issue":"13","key":"10.1016\/bs.acr.2020.01.003_bb0115","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1002\/cncr.26646","article-title":"Predicting the risk of chemotherapy toxicity in older patients: The chemotherapy risk assessment scale for high-age patients (CRASH) score","volume":"118","author":"Extermann","year":"2012","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/bs.acr.2020.01.003_bb0120","doi-asserted-by":"crossref","first-page":"263e","DOI":"10.1097\/01.prs.0000438062.53914.22","article-title":"Venous thromboembolism risk in mastectomy and immediate breast reconstruction: Analysis of the 2005 to 2011 American College of Surgeons National Surgical Quality Improvement Program data sets","volume":"133","author":"Fischer","year":"2014","journal-title":"Plastic and Reconstructive Surgery"},{"issue":"27","key":"10.1016\/bs.acr.2020.01.003_bb0125","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1200\/JCO.2016.72.1209","article-title":"Use of surveillance mammography among older breast cancer survivors by life expectancy","volume":"35","author":"Freedman","year":"2017","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1016\/bs.acr.2020.01.003_bb0130","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1001\/jamaoncol.2016.3931","article-title":"Surveillance mammography in older patients with breast cancer\u2014Can we ever stop? A review","volume":"3","author":"Freedman","year":"2017","journal-title":"JAMA Oncology"},{"issue":"11","key":"10.1016\/bs.acr.2020.01.003_bb0135","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1158\/1078-0432.CCR-16-2552","article-title":"Emerging data and current challenges for young, old, obese, or male patients with breast cancer","volume":"23","author":"Freedman","year":"2017","journal-title":"Clinical Cancer Research"},{"issue":"6","key":"10.1016\/bs.acr.2020.01.003_bb0140","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/cncr.20535","article-title":"Breast carcinoma in elderly women: Features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients","volume":"101","author":"Gennari","year":"2004","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/bs.acr.2020.01.003_bb0145","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11764-018-0682-z","article-title":"Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: A randomized controlled feasibility trial","volume":"12","author":"Graetz","year":"2018","journal-title":"Journal of Cancer Survivorship"},{"issue":"5","key":"10.1016\/bs.acr.2020.01.003_bb0150","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.breast.2013.03.001","article-title":"The use of adjuvant endocrine breast cancer therapy in the oldest old","volume":"22","author":"G\u00fcth","year":"2013","journal-title":"Breast"},{"issue":"1","key":"10.1016\/bs.acr.2020.01.003_bb0155","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.breast.2013.11.004","article-title":"Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: Results from the OMEGA study of the Dutch breast cancer trialists' group","volume":"23","author":"Hamaker","year":"2014","journal-title":"Breast"},{"issue":"1","key":"10.1016\/bs.acr.2020.01.003_bb0160","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-017-0034-x","article-title":"Precision cardio-oncology: Understanding the cardiotoxicity of cancer therapy","volume":"1","author":"Han","year":"2017","journal-title":"Nature Partner Journal (npj) Precision Oncology"},{"issue":"9","key":"10.1016\/bs.acr.2020.01.003_bb0165","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/cncr.29214","article-title":"Performance of digital screening mammography among older women in the United States","volume":"121","author":"Henderson","year":"2015","journal-title":"Cancer"},{"issue":"27","key":"10.1016\/bs.acr.2020.01.003_bb0170","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1200\/JCO.2009.25.9655","article-title":"Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients","volume":"28","author":"Hershman","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1016\/bs.acr.2020.01.003_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004272.pub2","article-title":"Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus)","author":"Hind","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"19","key":"10.1016\/bs.acr.2020.01.003_bb0180","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: Long-term follow-up of CALGB 9343","volume":"31","author":"Hughes","year":"2013","journal-title":"Journal of Clinical Oncology"},{"issue":"10","key":"10.1016\/bs.acr.2020.01.003_bb0185","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMoa040587","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer","volume":"351","author":"Hughes","year":"2004","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/bs.acr.2020.01.003_bb0190","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jgo.2016.06.003","article-title":"How should older adults with cancer be evaluated for frailty?","volume":"8","author":"Huisingh-Scheetz","year":"2017","journal-title":"Journal of Geriatric Oncology"},{"issue":"2","key":"10.1016\/bs.acr.2020.01.003_bb0195","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1040-8428(02)00133-6","article-title":"Factors influencing treatment patterns of breast cancer patients age 75 and older","volume":"46","author":"Hurria","year":"2003","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"20","key":"10.1016\/bs.acr.2020.01.003_bb0200","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1200\/JCO.2015.65.4327","article-title":"Validation of a prediction tool for chemotherapy toxicity in older adults with Cancer","volume":"34","author":"Hurria","year":"2016","journal-title":"Journal of Clinical Oncology"},{"issue":"27","key":"10.1016\/bs.acr.2020.01.003_bb0205","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJM199912303412706","article-title":"Underrepresentation of patients 65 years of age or older in cancer-treatment trials","volume":"341","author":"Hutchins","year":"1999","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1016\/bs.acr.2020.01.003_bb0210","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1200\/JCO.2005.01.5784","article-title":"Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: First results of International Breast Cancer Study Group Trial 10-93","volume":"24","author":"International Breast Cancer Study Group","year":"2006","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1016\/bs.acr.2020.01.003_bb0215","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.critrevonc.2005.04.008","article-title":"Prognostic impact of increasing age and co-morbidity in cancer patients: A population-based approach","volume":"55","author":"Janssen-Heijnen","year":"2005","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"10.1016\/bs.acr.2020.01.003_bb0220","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ypmed.2014.12.031","article-title":"Recent trends in adherence to continuous screening for breast cancer among Medicare beneficiaries","volume":"73","author":"Jiang","year":"2015","journal-title":"Preventive Medicine"},{"issue":"10","key":"10.1016\/bs.acr.2020.01.003_bb0225","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2217\/fon.15.13","article-title":"The role of primary endocrine therapy in older women with operable breast cancer","volume":"11","author":"Johnston","year":"2015","journal-title":"Future Oncology"},{"issue":"3","key":"10.1016\/bs.acr.2020.01.003_bb0230","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.amjsurg.2015.11.005","article-title":"Surgery and hormone therapy trends in octogenarians with invasive breast cancer","volume":"211","author":"Kantor","year":"2016","journal-title":"American Journal of Surgery"},{"issue":"1","key":"10.1016\/bs.acr.2020.01.003_bb0235","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1200\/JCO.2005.02.4174","article-title":"Factors related to underuse of surveillance mammography among breast cancer survivors","volume":"24","author":"Keating","year":"2006","journal-title":"Journal of Clinical Oncology"},{"issue":"12","key":"10.1016\/bs.acr.2020.01.003_bb0240","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1200\/JCO.2003.09.124","article-title":"Barriers to clinical trial participation by older women with breast cancer","volume":"21","author":"Kemeny","year":"2003","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1016\/bs.acr.2020.01.003_bb0245","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/bjc.2017.202","article-title":"Geriatric assessment is superior to oncologists' clinical judgement in identifying frailty","volume":"117","author":"Kirkhus","year":"2017","journal-title":"British Journal of Cancer"},{"issue":"5","key":"10.1016\/bs.acr.2020.01.003_bb0250","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/07357907.2016.1182184","article-title":"Breast cancer subtypes in patients aged 70 years and older","volume":"34","author":"K\u00f6nigsberg","year":"2016","journal-title":"Cancer Investigation"},{"issue":"5","key":"10.1016\/bs.acr.2020.01.003_bb0255","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/cncr.10792","article-title":"Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials","volume":"95","author":"Kornblith","year":"2002","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/bs.acr.2020.01.003_bb0260","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.amjsurg.2017.05.008","article-title":"Disparities in compliance with the Oncotype DX breast cancer test in the United States: A National Cancer Data Base assessment","volume":"215","author":"Kozick","year":"2018","journal-title":"American Journal of Surgery"},{"issue":"Suppl. 1","key":"10.1016\/bs.acr.2020.01.003_bb0265","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.breast.2017.06.032","article-title":"Age, molecular subtypes and local therapy decision-making","volume":"34","author":"Kuijer","year":"2017","journal-title":"Breast"},{"issue":"3","key":"10.1016\/bs.acr.2020.01.003_bb0270","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1470-2045(14)71221-5","article-title":"Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): A randomized controlled trial","volume":"16","author":"Kunkler","year":"2015","journal-title":"The Lancet Oncology"},{"key":"10.1016\/bs.acr.2020.01.003_bb0275","first-page":"157","article-title":"Optimal management of breast cancer in the elderly patient: Current perspectives","volume":"10","author":"Le Saux","year":"2015","journal-title":"Clinical Interventions in Aging"},{"issue":"7","key":"10.1016\/bs.acr.2020.01.003_bb0280","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1200\/JCO.2003.08.010","article-title":"Participation of patients 65 years of age or older in cancer clinical trials","volume":"21","author":"Lewis","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/bs.acr.2020.01.003_bb0285","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13058-015-0525-z","article-title":"Benefits and harms of mammography screening","volume":"17","author":"L\u00f8berg","year":"2015","journal-title":"Breast Cancer Research"},{"issue":"20","key":"10.1016\/bs.acr.2020.01.003_bb0290","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1002\/cncr.24510","article-title":"Patient-physician communication in breast reconstructive surgery","volume":"115","author":"Maly","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/bs.acr.2020.01.003_bb0295","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1477-7525-1-45","article-title":"Outcomes and quality of life following breast cancer treatment in older women: When, why, how much, and what do women want?","volume":"1","author":"Mandelblatt","year":"2003","journal-title":"Health and Quality of Life Outcomes"},{"issue":"3","key":"10.1016\/bs.acr.2020.01.003_bb0300","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/1097-0142(20000801)89:3<561::AID-CNCR11>3.0.CO;2-A","article-title":"Patterns of breast carcinoma treatment in older women: Patient preference and clinical and physical influences","volume":"89","author":"Mandelblatt","year":"2000","journal-title":"Cancer"},{"issue":"18","key":"10.1016\/bs.acr.2020.01.003_bb0305","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1200\/JCO.2013.54.2050","article-title":"Cognitive impairment in older patients with breast cancer before systemic therapy: Is there an interaction between cancer and comorbidity?","volume":"32","author":"Mandelblatt","year":"2014","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1016\/bs.acr.2020.01.003_bb0310","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1158\/1055-9965.EPI-16-0889","article-title":"Estimation of the number of women living with metastatic breast cancer in the United States","volume":"26","author":"Mariotto","year":"2017","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"2","key":"10.1016\/bs.acr.2020.01.003_bb0315","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jnci\/djq495","article-title":"Projections of the cost of cancer care in the United States: 2010-2020","volume":"103","author":"Mariotto","year":"2011","journal-title":"Journal of the National Cancer Institute"},{"issue":"6","key":"10.1016\/bs.acr.2020.01.003_bb0320","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/1758834012455684","article-title":"Older patients with breast cancer: Is there bias in the treatment they receive?","volume":"4","author":"Markopoulos","year":"2012","journal-title":"Therapeutic Advances in Medical Oncology"},{"issue":"1","key":"10.1016\/bs.acr.2020.01.003_bb0325","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10549-013-2710-z","article-title":"Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: Subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)","volume":"142","author":"Miles","year":"2013","journal-title":"Breast Cancer Research and Treatment"},{"issue":"16","key":"10.1016\/bs.acr.2020.01.003_bb0330","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1002\/cncr.30053","article-title":"Improving the quality of survivorship for older adults with cancer","volume":"122","author":"Mohile","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/bs.acr.2020.01.003_bb0335","article-title":"Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus)","author":"Morgan","year":"2014","journal-title":"Cochrane Breast Cancer Group"},{"issue":"Suppl. 5","key":"10.1016\/bs.acr.2020.01.003_bb0340","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1634\/theoncologist.2010-S5-57","article-title":"Coming of age: Breast cancer in seniors","volume":"15","author":"Muss","year":"2010","journal-title":"The Oncologist"},{"issue":"20","key":"10.1016\/bs.acr.2020.01.003_bb0345","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa0810266","article-title":"Adjuvant chemotherapy in older women with early-stage breast cancer","volume":"360","author":"Muss","year":"2009","journal-title":"The New England Journal of Medicine"},{"issue":"12","key":"10.1016\/bs.acr.2020.01.003_bb0350","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1200\/JCO.2007.12.6334","article-title":"Efficacy, toxicity, and quality of life in older women with early-stage breast cancer treated with letrozole or placebo after 5 years of tamoxifen: NCIC CTG intergroup trial MA.17","volume":"26","author":"Muss","year":"2008","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1016\/bs.acr.2020.01.003_bb0355","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2147\/TCRM.S1566","article-title":"Long-term safety of aromatase inhibitors in the treatment of breast cancer","volume":"4","author":"Nabholtz","year":"2008","journal-title":"Therapeutics and Clinical Risk Management"},{"issue":"3","key":"10.1016\/bs.acr.2020.01.003_bb0360","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/COC.0000000000000144","article-title":"Older patients wih early-stage breast cancer: Adjuvant radiation therapy and predictive factors for cancer-related death","volume":"40","author":"Nagar","year":"2017","journal-title":"American Journal of Clinical Oncology"},{"key":"10.1016\/bs.acr.2020.01.003_bb0365","author":"NCCN"},{"issue":"4","key":"10.1016\/bs.acr.2020.01.003_bb0370","doi-asserted-by":"crossref","first-page":"226","DOI":"10.7326\/M15-0971","article-title":"Factors associated with rates of false-positive and false-negative results from digital mammography screening: An analysis of registry data","volume":"164","author":"Nelson","year":"2016","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/bs.acr.2020.01.003_bb0375","doi-asserted-by":"crossref","unstructured":"Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L (2009). U.S. Preventive Services Task Force. Screening for breast cancer: An update for the U.S. Preventive Services Task Force. Annals of Internal Medicine 151 (10), 727\u201337, W237-42. doi:https:\/\/doi.org\/10.7326\/0003-4819-151-10-200911170-00009.","DOI":"10.7326\/0003-4819-151-10-200911170-00009"},{"issue":"6","key":"10.1016\/bs.acr.2020.01.003_bb0380","first-page":"341","article-title":"Managing breast cancer in the older patient","volume":"11","author":"O'Connor","year":"2013","journal-title":"Clinical Advances in Hematology & Oncology"},{"issue":"5","key":"10.1016\/bs.acr.2020.01.003_bb0385","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.whi.2010.04.002","article-title":"Adherence to mammography and colorectal cancer screening in women 50-80 years of age the role of psychological distress","volume":"20","author":"O'Donnell","year":"2010","journal-title":"Womens Health Issues"},{"issue":"15","key":"10.1016\/bs.acr.2020.01.003_bb0390","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1001\/jama.2015.12783","article-title":"Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society","volume":"314","author":"Oeffinger","year":"2015","journal-title":"Journal of the American Medical Association"},{"issue":"3","key":"10.1016\/bs.acr.2020.01.003_bb0395","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<653::AID-CNCR24>3.0.CO;2-1","article-title":"Cancer and comorbidity: Redefining chronic diseases","volume":"88","author":"Ogle","year":"2000","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/bs.acr.2020.01.003_bb0400","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/pon.4895","article-title":"Patient-reported outcomes of breast reconstruction in older women: Audit of a large metropolitan public\/private practice in Sydney, Australia","volume":"27","author":"Oh","year":"2018","journal-title":"Psychooncology"},{"issue":"5","key":"10.1016\/bs.acr.2020.01.003_bb0405","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ejso.2016.02.010","article-title":"Patterns and outcomes of breast reconstruction in older women\u2014A systematic review of the literature","volume":"242","author":"Oh","year":"2016","journal-title":"European Journal of Surgical Oncology"},{"issue":"12","key":"10.1016\/bs.acr.2020.01.003_bb0410","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1245\/s10434-017-6075-0","article-title":"Patient age and tumor subtype predict the extent of axillary surgery among breast cancer patients eligible for the American College of Surgeons Oncology Group Trial Z0011","volume":"24","author":"Ong","year":"2017","journal-title":"Annals of Surgical Oncology"},{"issue":"3","key":"10.1016\/bs.acr.2020.01.003_bb0415","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.3390\/cancers7030846","article-title":"Breast cancer in elderly Caucasian women-an institution-based study of correlation between breast cancer prognostic markers, TNM stage, and overall survival","volume":"7","author":"Orucevic","year":"2015","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/bs.acr.2020.01.003_bb0420","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1308\/003588411X571917","article-title":"Is primary endocrine therapy effective in treating the elderly, unfit patient with breast cancer?","volume":"93","author":"Osborn","year":"2011","journal-title":"Annals of the Royal College of Surgeons of England"},{"issue":"27","key":"10.1016\/bs.acr.2020.01.003_bb0425","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","article-title":"A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer","volume":"351","author":"Paik","year":"2004","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.acr.2020.01.003_bb0430","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/jnci\/djr188","article-title":"The influence of comorbidities on overall survival among older women diagnosed with breast cancer","volume":"103","author":"Patnaik","year":"2011","journal-title":"Journal of the National Cancer Institute"},{"issue":"4","key":"10.1016\/bs.acr.2020.01.003_bb0435","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/annonc\/mdu564","article-title":"Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: Final results of the randomized phase III ELDA trial","volume":"26","author":"Perrone","year":"2015","journal-title":"Annals of Oncology"},{"issue":"26","key":"10.1016\/bs.acr.2020.01.003_bb0440","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1200\/JCO.2017.73.6546","article-title":"Charting the future of cancer health disparities research: A position statement from the American Association for Cancer Research, the American Cancer Society, the American Society of Clinical Oncology, and the National Cancer Institute","volume":"35","author":"Polite","year":"2017","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/bs.acr.2020.01.003_bb0445","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/bjc.2011.234","article-title":"The treatment of early breast cancer in women over the age of 70","volume":"105","author":"Ring","year":"2011","journal-title":"British Journal of Cancer"},{"key":"10.1016\/bs.acr.2020.01.003_bb0450","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejca.2018.05.017","article-title":"Palbociclib plus endocrine therapy in older women with HR+\/HER2- advanced breast cancer: A pooled analysis of randomised PALOMA clinical studies","volume":"101","author":"Rugo","year":"2018","journal-title":"European Journal of Cancer"},{"issue":"6","key":"10.1016\/bs.acr.2020.01.003_bb0455","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jamcollsurg.2016.09.003","article-title":"Effect of patient age on outcomes in breast reconstruction: Results from a multicenter prospective study","volume":"2223","author":"Santosa","year":"2016","journal-title":"Journal of the American College of Surgeons"},{"key":"10.1016\/bs.acr.2020.01.003_bb0460","first-page":"113","article-title":"Aromatase inhibitors in the treatment of breast cancer in post-menopausal female patients: An update","volume":"3","author":"Schneider","year":"2011","journal-title":"Breast Cancer (Dove Med Press)"},{"issue":"12","key":"10.1016\/bs.acr.2020.01.003_bb0465","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1111\/jgs.14503","article-title":"Decision-making regarding mammography screening for older women","volume":"64","author":"Schonberg","year":"2016","journal-title":"Journal of the American Geriatrics Society"},{"issue":"12","key":"10.1016\/bs.acr.2020.01.003_bb0470","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.2009.25.9796","article-title":"Breast cancer among the oldest old: Tumor characteristics, treatment choices, and survival","volume":"28","author":"Schonberg","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1016\/bs.acr.2020.01.003_bb0475","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10549-014-2921-y","article-title":"Factors noted to affect women aged 80 and older's breast cancer treatment decisions","volume":"145","author":"Schonberg","year":"2014","journal-title":"Breast Cancer Research and Treatment"},{"key":"10.1016\/bs.acr.2020.01.003_bb0480","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2318-8-24","article-title":"A standard procedure for creating a frailty index","volume":"8","author":"Searle","year":"2008","journal-title":"BMC Geriatrics"},{"issue":"1","key":"10.1016\/bs.acr.2020.01.003_bb0485","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11764-012-0239-5","article-title":"Decline in physical functioning in first 2 years after breast cancer diagnosis predicts 10-year survival in older women","volume":"7","author":"Sehl","year":"2013","journal-title":"Journal of Cancer Survivorship"},{"issue":"2","key":"10.1016\/bs.acr.2020.01.003_bb0490","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1200\/JOP.2015.010207","article-title":"Breast Cancer in women older than 80 years","volume":"12","author":"Shachar","year":"2016","journal-title":"Journal of Oncology Practice"},{"issue":"22","key":"10.1016\/bs.acr.2020.01.003_bb0495","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1200\/JCO.2013.51.7367","article-title":"Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901","volume":"32","author":"Sheppard","year":"2014","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/bs.acr.2020.01.003_bb0500","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/cncr.20206","article-title":"The natural history of breast carcinoma in the elderly\u2014Implications for screening and treatment","volume":"100","author":"Singh","year":"2004","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/bs.acr.2020.01.003_bb0505","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s40266-015-0326-1","article-title":"Targeted agents for HER2-positive breast cancer: Optimal use in older patients","volume":"32","author":"Singh","year":"2015","journal-title":"Drugs & Aging"},{"issue":"35","key":"10.1016\/bs.acr.2020.01.003_bb0510","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1200\/JCO.2011.35.8408","article-title":"Improvement in breast cancer outcomes over time: Are older women missing out?","volume":"29","author":"Smith","year":"2011","journal-title":"Journal of Clinical Oncology"},{"issue":"6","key":"10.1016\/bs.acr.2020.01.003_bb0515","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1470-2045(13)70130-X","article-title":"Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): Overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study","volume":"14","author":"Swain","year":"2013","journal-title":"The Lancet Oncology"},{"issue":"12","key":"10.1016\/bs.acr.2020.01.003_bb0520","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1007\/s12325-015-0268-3","article-title":"Quantitative gene expression by recurrence score in ER-positive breast cancer, by age","volume":"32","author":"Swain","year":"2015","journal-title":"Advances in Therapy"},{"issue":"1","key":"10.1016\/bs.acr.2020.01.003_bb0525","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.rpor.2012.05.005","article-title":"Breast cancer in the elderly\u2014Should it be treated differently?","volume":"18","author":"Tesarova","year":"2013","journal-title":"Reports of Practical Oncology and Radiotherapy"},{"key":"10.1016\/bs.acr.2020.01.003_bb0530","doi-asserted-by":"crossref","first-page":"1381695","DOI":"10.1155\/2016\/1381695","article-title":"Specific aspects of breast cancer therapy of elderly women","volume":"2016","author":"Tesarova","year":"2016","journal-title":"BioMed Research International"},{"issue":"12","key":"10.1016\/bs.acr.2020.01.003_bb0535","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.2217\/fon.13.140","article-title":"Breast cancer in the elderly: Which lessons have we learned?","volume":"9","author":"Turner","year":"2013","journal-title":"Future Oncology"},{"issue":"10","key":"10.1016\/bs.acr.2020.01.003_bb0540","doi-asserted-by":"crossref","first-page":"716","DOI":"10.7326\/0003-4819-151-10-200911170-00008","article-title":"Screening for breast cancer: U.S. preventative services task force recommendation statement","volume":"151","author":"US Preventative Services Task Force (USPSTF)","year":"2009","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1016\/bs.acr.2020.01.003_bb0545","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cger.2011.10.002","article-title":"Early breast cancer in the older woman","volume":"28","author":"VanderWalde","year":"2012","journal-title":"Clinics in Geriatric Medicine"},{"issue":"1","key":"10.1016\/bs.acr.2020.01.003_bb0550","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/0284186X.2012.731523","article-title":"Breast cancer in women 80 years of age and older: A comprehensive analysis of an underreported entity","volume":"52","author":"Vetter","year":"2013","journal-title":"Acta Oncologica"},{"issue":"13","key":"10.1016\/bs.acr.2020.01.003_bb0555","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1001\/jama.2014.2834","article-title":"Screening mammography in older women: A review","volume":"311","author":"Walter","year":"2014","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/bs.acr.2020.01.003_bb0560","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S1470-2045(07)70378-9","article-title":"Management of breast cancer in elderly individuals: Recommendations of the International Society of Geriatric Oncology","volume":"8","author":"Wildiers","year":"2007","journal-title":"The Lancet Oncology"},{"issue":"18","key":"10.1016\/bs.acr.2020.01.003_bb0565","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1200\/JCO.2008.16.7619","article-title":"Relationship between age and axillary lymph node involvement in women with breast cancer","volume":"27","author":"Wildiers","year":"2009","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1016\/bs.acr.2020.01.003_bb0570","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jgo.2015.12.002","article-title":"Comorbidity in older adults with cancer","volume":"7","author":"Williams","year":"2016","journal-title":"Journal of Geriatric Oncology"},{"issue":"4","key":"10.1016\/bs.acr.2020.01.003_bb0575","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1245\/s10434-011-2070-z","article-title":"Hormone treatment without surgery for patients aged 75 years or older with operable breast cancer","volume":"19","author":"Wink","year":"2012","journal-title":"Annals of Surgical Oncology"},{"issue":"7","key":"10.1016\/bs.acr.2020.01.003_bb0580","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/(SICI)1097-0142(19971001)80:7<1273::AID-CNCR13>3.0.CO;2-4","article-title":"Cancer burden in the aged: An epidemiologic and demographic overview","volume":"80","author":"Yancik","year":"1997","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/bs.acr.2020.01.003_bb0585","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.285.7.885","article-title":"Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older","volume":"285","author":"Yancik","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/bs.acr.2020.01.003_bb0590","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1038\/srep02246","article-title":"The impact of p53 in predicting clinical outcome of breast cancer patients with visceral metastasis","volume":"3","author":"Yang","year":"2013","journal-title":"Scientific Reports"},{"issue":"5","key":"10.1016\/bs.acr.2020.01.003_bb0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128345","article-title":"Age-related disparity in immediate prognosis of patients with triple-negative breast cancer: A population-based study from SEER cancer registries","volume":"10","author":"Zhu","year":"2015","journal-title":"PLoS One"},{"issue":"8\u20139","key":"10.1016\/bs.acr.2020.01.003_bb0600","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/0959-8049(92)90547-F","article-title":"The influence of age on treatment choice and survival of elderly breast cancer patients in South-Eastern Netherlands: A population-based study","volume":"28A","author":"Bergman","year":"1992","journal-title":"European Journal of Cancer"},{"issue":"4","key":"10.1016\/bs.acr.2020.01.003_bb0605","doi-asserted-by":"crossref","first-page":"e148","DOI":"10.1016\/S1470-2045(11)70383-7","article-title":"Management of elderly patients with breast cancer: Updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)","volume":"13","author":"Biganzoli","year":"2012","journal-title":"The Lancet Oncology"},{"key":"10.1016\/bs.acr.2020.01.003_bb9005","unstructured":"Clinical Treatment Score post 5 years. CTS5 calculator. https:\/\/www.cts5-calculator.com\/."},{"issue":"1","key":"10.1016\/bs.acr.2020.01.003_bb0610","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13643-016-0345-y","article-title":"Utilization of screening mammography in older women according to comorbidity and age: Protocol for a systematic review","volume":"5","author":"Demb","year":"2016","journal-title":"Systematic Reviews"},{"key":"10.1016\/bs.acr.2020.01.003_bb0615","first-page":"569e75","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/bs.acr.2020.01.003_bb0620","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/tbj.12233","article-title":"A prediction model for the presence of axillary lymph node involvement in women with invasive breast cancer: A focus on older women","volume":"20","author":"Greer","year":"2014","journal-title":"The Breast Journal"},{"issue":"7","key":"10.1016\/bs.acr.2020.01.003_bb0625","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/sj.bjc.6603600","article-title":"Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: Cochrane review","volume":"96","author":"Hind","year":"2007","journal-title":"British Journal of Cancer"},{"issue":"15","key":"10.1016\/bs.acr.2020.01.003_bb0630","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.ejca.2007.08.005","article-title":"Clinical epidemiology of breast cancer in the elderly","volume":"43","author":"Louwman","year":"2007","journal-title":"European Journal of Cancer"},{"issue":"1","key":"10.1016\/bs.acr.2020.01.003_bb0635","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10549-017-4222-8","article-title":"Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance)","volume":"164","author":"Mandelblatt","year":"2017","journal-title":"Breast Cancer Research and Treatment"},{"issue":"2","key":"10.1016\/bs.acr.2020.01.003_bb0640","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10549-012-2114-5","article-title":"Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: A systematic review","volume":"134","author":"Murphy","year":"2012","journal-title":"Breast Cancer Research and Treatment"},{"key":"10.1016\/bs.acr.2020.01.003_bb0645","unstructured":"National Cancer Institute Surveillance, n.d. \u201cEpidemiology and End Results: Breast cancer incidence and mortality,\u201d http:\/\/seer.cancer.gov\/statfacts\/html\/breast.html."},{"key":"10.1016\/bs.acr.2020.01.003_bb0650","unstructured":"NCT02476786. Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02476786 Accessed September 2018 n.d.."},{"key":"10.1016\/bs.acr.2020.01.003_bb0655","unstructured":"NCT02737839. Adaptation of the STEPPING ON Fall Prevention Program for Older Adults Receiving Cancer Therapy. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02737839. Accessed September 2018 n.d."},{"key":"10.1016\/bs.acr.2020.01.003_bb0660","unstructured":"NCT02823262. A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02823262 Accessed September 2018 n.d."},{"key":"10.1016\/bs.acr.2020.01.003_bb0665","unstructured":"NCT02912273. Optimizing Fall-risk Prediction in Older Adults With Cancer. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02912273 Accessed September 2018 n.d."},{"key":"10.1016\/bs.acr.2020.01.003_bb0670","unstructured":"NCT03143829 Promoting Cancer Symptom Management in Older Adults. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03143829. Accessed September 2018 n.d."},{"key":"10.1016\/bs.acr.2020.01.003_bb0675","unstructured":"NCT03168971. Managing Anxiety From Cancer (MAC): Testing an Intervention for Anxiety in Older Adults With Cancer and Their Caregivers. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03168971 Accessed September 2018 n.d."},{"key":"10.1016\/bs.acr.2020.01.003_bb0680","unstructured":"NCT03633331. Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03633331 Accessed September 2018 n.d."},{"key":"10.1016\/bs.acr.2020.01.003_bb0685","author":"Social Security Administration"},{"key":"10.1016\/bs.acr.2020.01.003_bb0690","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1525-1497.2001.10113.x","article-title":"Screening mammography for frail older women: What are the burdens?","volume":"16","author":"Walter","year":"2001","journal-title":"Journal of General Internal Medicine"}],"container-title":["Advances in Cancer Research","Cancer Health Equity Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065230X20300038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065230X20300038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T19:13:02Z","timestamp":1758741182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065230X20300038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9780128201763"],"references-count":138,"URL":"https:\/\/doi.org\/10.1016\/bs.acr.2020.01.003","relation":{},"ISSN":["0065-230X"],"issn-type":[{"value":"0065-230X","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}